Citigroup
EXAS

Citigroup’s Exact Sciences EXAS Stock Holding History

Citigroup’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-266,900
Closed -$18.4M – 5637
2024
Q1 		$18.4M Buy
+266,900
New +$16.9M 0.01% 916
2023
Q2 		– Sell
-40,000
Closed -$2.71M – 5608
2023
Q1 		$2.71M Buy
+40,000
New +$2.57M ﹤0.01% 1815
2022
Q3 		– Sell
-20,000
Closed -$788K – 5971
2022
Q2 		$788K Buy
+20,000
New +$1.07M ﹤0.01% 2867
2021
Q1 		– Sell
-85,700
Closed -$11.4M – 6594
2020
Q4 		$11.4M Buy
85,700
+6,800
+9% +$822K 0.01% 1451
2020
Q3 		$8.04M Buy
78,900
+11,800
+18% +$1.02M 0.01% 1542
2020
Q2 		$5.83M Sell
67,100
-2,300
-3% -$184K ﹤0.01% 1722
2020
Q1 		$4.03M Sell
69,400
-64,400
-48% -$5.23M ﹤0.01% 1856
2019
Q4 		$12.4M Buy
133,800
+43,400
+48% +$3.82M 0.01% 1304
2019
Q3 		$8.17M Buy
90,400
+37,100
+70% +$4.23M 0.01% 1545
2019
Q2 		$6.29M Sell
53,300
-18,500
-26% -$1.86M 0.01% 1777
2019
Q1 		$6.22M Sell
71,800
-71,000
-50% -$6.04M 0.01% 1615
2018
Q4 		$9.01M Sell
142,800
-162,600
-53% -$11.2M 0.01% 1332
2018
Q3 		$24.1M Buy
305,400
+196,100
+179% +$12.8M 0.02% 730
2018
Q2 		$6.54M Buy
109,300
+76,900
+237% +$4.14M 0.01% 1605
2018
Q1 		$1.31M Sell
32,400
-16,000
-33% -$781K ﹤0.01% 3017
2017
Q4 		$2.54M Sell
48,400
-26,400
-35% -$1.41M ﹤0.01% 2444
2017
Q3 		$3.52M Buy
74,800
+17,700
+31% +$712K ﹤0.01% 2077
2017
Q2 		$2.02M Sell
57,100
-167,200
-75% -$5.16M ﹤0.01% 2580
2017
Q1 		$5.3M Buy
224,300
+207,200
+1,212% +$4.11M ﹤0.01% 1624
2016
Q4 		$228K Sell
17,100
-6,900
-29% -$111K ﹤0.01% 5168
2016
Q3 		$446K Sell
24,000
-5,100
-18% -$89.9K ﹤0.01% 3993
2016
Q2 		$356K Buy
29,100
+13,500
+87% +$102K ﹤0.01% 3985
2016
Q1 		$105K Sell
15,600
-1,400
-8% -$8.96K ﹤0.01% 5634
2015
Q4 		$157K Sell
17,000
-6,500
-28% -$60.4K ﹤0.01% 4958
2015
Q3 		$423K Sell
23,500
-12,200
-34% -$280K ﹤0.01% 3905
2015
Q2 		$1.06M Buy
35,700
+23,000
+181% +$578K ﹤0.01% 3109
2015
Q1 		$280K Sell
12,700
-987,300
-99% -$25M ﹤0.01% 4226
2014
Q4 		$27.4M Hold
1,000,000
– – 0.02% 643
2014
Q3 		$19.4M Hold
1,000,000
– – 0.02% 828
2014
Q2 		$17M Hold
1,000,000
– – 0.02% 895
2014
Q1 		$14.2M Hold
1,000,000
– – 0.01% 924
2013
Q4 		$11.7M Hold
1,000,000
– – 0.01% 1127
2013
Q3 		$11.8M Buy
1,000,000
+990,000
+9,900% +$12.7M 0.01% 1043
2013
Q2 		$139K Buy
+10,000
New +$109K ﹤0.01% 4578

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Citigroup's EXAS Position: Q1 2026 in Review

Citigroup sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 146,862 shares — an estimated $14.9M sold.

Citigroup first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $110M in Q4 2017. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Citigroup reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 146,862 Exact Sciences shares in Q1 2026, an estimated $14.9M.
  • Citigroup first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Citigroup's Exact Sciences position peaked at $110M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.